Full Length Research Paper
References
|
Adibhatla RM, Hatcher JF (2008). Phospholipase A2, reactive oxygen species, and lipid peroxidation in CNS pathologies. BMB Rep. 41(8):560-567. Crossref |
||||
|
Berg BM, Godbout JP, Kelley KW, Johnson RW (2004). Alpha-tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain Behavior and Immunity 18:149–157. Crossref |
||||
|
Bradley PP, Christensen RD, Rothstein G (1982). Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60(3):618-622. PubMed |
||||
|
Bruunsgaard H, Pedersen M, Pedersen BK (2001). Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8:131–136. Crossref |
||||
|
Buege JA, Aust SD (1978). Microsomal lipid peroxidation. Methods Enzymol. 52:302-310. Crossref |
||||
|
Buhl SN, Jackson KY (1978). Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clin. Chem. 24(5):828-831. PubMed |
||||
|
Calabro P, Limongelli G, Pacileo G, Di Salvo G, Golino P, Calabro R (2008). The role of adiposity as a determinant of an inflammatory milieu. J. Cardiovasc. Med. 9:450-460. Crossref |
||||
|
Chander V, Tirkey N, Chopra K (2005). Resveratrol, a polyphenolicphytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology 210:55-64. Crossref |
||||
|
Chen XY, Wang ZC, Li J, Liu XL, Sun YH (2013). Regulation of synoviocyte activity by resveratrol in rats with adjuvant arthritis. Exp. Ther. Med. 6:172-176. PubMed |
||||
|
Choi DW (1988). Calcium-mediated neurotoxicity: Relationship to specific channel types and role inischemic damage. Trends Neurosci. 11:465-469. Crossref |
||||
|
Csiszar A (2011). Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease. Ann. NY Acad. Sci. 1215:117-122. Crossref |
||||
|
Dajas F, Rivera-Megret F, Blasina F, Arredondo F, Abin-Carriquiry JA, Costa G, Echeverry C, Lafon L, Heizen H, Ferreira M (2003). Neuroprotection by flavonoids. Braz. J. Med. Biol. Res. 36:1613-1620. Crossref |
||||
|
De la Lastra CA, Villegas I (2005). Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49:405-430. Crossref |
||||
|
Docherty JJ, Fu MM, Hah JM, Sweet TJ, Faith SA, Booth T (2005). Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. Antiviral Res. 67:155-162. Crossref |
||||
|
Doganay S, Borazan M, Iraz M, Cigremis Y (2006). The effect of resveratrol in experimental cataract model formed by sodium selenite. Curr. Eye Res. 31:147-153. Crossref |
||||
|
Fisher M, Schaebitz W (2000). An overview of acute stroke therapy: past, present, and future. Arch. Intern. Med. 160(21):3196-3206. Crossref |
||||
|
Frankel EN, Waterhouse AL, Kinsella JE (1993). Inhibition of human LDL oxidationby resveratrol. Lancet. 341:1103-1104. Crossref |
||||
|
Garcia-Estrada J, Gonzalez-Perez O, Gonzalez-Castaneda RE, Martinez-Contreras A, Luquin S, de la Mora PG, Navarro-Ruiz A (2003). An alpha-lipoic acid-vitamin E mixture reduces postembolism lipid peroxidation, cerebral infarction, and neurological deficit in rats. Neurosci. Res. 47:219-224. Crossref |
||||
|
Gedik E1 Girgin S, Ozturk H, Obay BD, Ozturk H, Buyukbayram H (2008). Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J. Gastroenterol. 14(46):7101-7106. Crossref |
||||
|
Godbout JP, Berg BM, Kelley KW, Johnson RW (2004). Alpha-Tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. J. Neuroimmunol. 149:101-109. Crossref |
||||
|
GümüÅŸtaÅŸ K, Meta Güzeyli FM, Atükeren P, Sanus GZ, Kemerdere R, Tanriverdi T, Kaynar MY (2007). The effects of vitamin E on lipid peroxidation, nitric oxide production and superoxide dismutase expression in hyperglycemic rats with cerebral ischemia-reperfusion injury. Turk. Neurosurg. 17(2):78-82. PubMed |
||||
|
Halliwell B (2008). Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch. Biochem. Biophys. 476:107-112. Crossref |
||||
|
Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R (2004). Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br. J. Pharmacol. 141(6):997-1005. Crossref |
||||
|
Hao HD,He LR (2004). Mechanisms of cardiovascular protection by resveratrol. J. Med. Food. 7(3):290-298. Crossref |
||||
|
Huang TC, Lu KT, Wo YY, Wu YJ, Yang YL (2011). Resveratrol protects rats from a beta-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. Plos One 6(12):e29102. Crossref |
||||
|
Jatana M, Singh I, Singh AK, Jenkins D (2006). Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res. 59:684-689. Crossref |
||||
|
Jeong MH, Yang KM, Jeong DH, Lee CG, Oh SJ, Jeong SK, Lee KW, Jo YR, Jo WS (2014). Protective activity of a novel resveratrol analogue, HS-1793, against DNA damage in 137Cs-irradiated CHO-K1 cells. J. Radiat. Res. [Epub ahead of print]. Crossref |
||||
|
Kashif R, Zaidi SM, Banu N (2004). Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain. Clin. Chim. Acta. 340:229-233. Crossref |
||||
|
Knuckey NW, Palm D, Primiano M, Epstein MH,Johanson CE (1995).N-acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke 26:305-310. Crossref |
||||
|
Kogure K, Watson BD, Busto R, Abe K (1992). Potentiation of lipid peroxides by ischemia in rat brain. Neurochem. Res. 7(4):437-454. Crossref |
||||
|
Kubota S, Kurihara T, Mochimaru H, Satofuka S, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K (2009). Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest. Ophthalmol. Vis. Sci. 50(7):3512-3519. Crossref |
||||
|
Lee JM, Zipfel GJ,Choi DW (1999). The changing landscape of ischaemic brain injury mechanisms. Nature 399(6738 Suppl):A7-14. Crossref |
||||
|
Lu X, Xu H, Sun B, Zhu Z, Zheng D, Li X (2013). Enhanced neuroprotective effects of resveratrol delivered by nanoparticles on hydrogen peroxide-induced oxidative stress in rat cortical cell culture. Mol. Pharm. 10(5):2045-2053. Crossref |
||||
|
Luzi C, Brisdelli F, Cinque B, Bozzi GCA (2004). Differential sensitivity to resveratrol-induced apoptosis of human chronic myeloid (K562) and acute Iymphoblastic (HSB-2) Leukemia cells. Biochem. Pharmacol. 68:2019-2030. Crossref |
||||
|
Martins E, Inamura K, Themner K, Malmqvist KG, Siesjö BK (1988). Accumulation of calcium and loss of potassium in the hippocampus following transient cerebral ischemia: A proton microprobe study. J. Cereb. Blood Flow Metab. 8:531-538. Crossref |
||||
|
Migliore L, Coppede F (2009). Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat. Res. 674:73-84. Crossref |
||||
|
Mishima K, Tanaka T, Pu F, Egashira N, Iwasaki K, Hidaka R, Matsunaga K, Takata J, Karube Y, Fujiwara M (2003). Vitamin E isoforms •-tocotrienol and Á-tocopherol prevent cerebral infarction in mice. Neurosci. Lett. 337:56-60. Crossref |
||||
|
Moncada S, Palmer RM, Higgs EA (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142. PubMed |
||||
|
Moro MA, Cárdenas A, Hurtado O, Leza JC, Lizasoain I (2004). Role of nitric oxide after brain ischaemia. Cell Calcium 36(3-4):265-275. Crossref |
||||
|
Mozaffarieh M, Grieshaber MC, Orgül S, Flammer J (2008). The potential value of natural antioxidative treatment in glaucoma. Surv. Ophthalmol. 53(5):479-505. Crossref |
||||
|
Norata GD, Marchesi P, Passamonti S, Pirillo A, Violi F, Catapano AL (2007). Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 191:265-271. Crossref |
||||
|
Panickar KS, Norenberg MD (2005). Astrocytes in cerebral ischemic injury: Morphological and general considerations. Glia. 50:287-298. Crossref |
||||
|
Raval AP, Dave KR, Pérez-Pinzón MA (2006). Resveratrol mimics ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 26(9):1141-1147. PubMed |
||||
|
Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ,Perez-Pinzon MA (2008). Resveratrol and ischemic preconditioning in the brain. Curr. Med. Chem.15(15):1545-1551. Crossref |
||||
|
Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK (1999). The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic. Biol. Med. 27(1-2):160-169. Crossref |
||||
| Rodrigo R, Bosco C (2006). Oxidative stress and protective effects of polyphenols: Comparative studies in human and rodent kidney. Biochem. Physiol. 142:317-327. | ||||
|
Schuett H, Oestreich R, Waetzig GH, Annema W, Luchtefeld M, Hillmer A, Bavendiek U, von Felden J, Divchev D, Kempf T (2012).Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice. Arteriosclerosis 32:281-290. Crossref |
||||
|
Seif-El-Nasr M, El-Fattah AA (1995). Lipid peroxide, phospholipids, glutathione' levels and superoxide dismutase activity in rat brain after ischaemia: effect of Ginkgo biloba extract. Pharmacol. Res. 32:273-278. Crossref |
||||
|
Seif-El-Nasr NM, Nuglisch J, Krieglstein J (1992). Prevention of ischemia-induce cerebral hypothermia by controlling the environmental temperature. J. Pharmacol. Toxicol. Methods. 27:23-26. Crossref |
||||
|
Sekhon B, Sekhon C, Khan M, Patel SJ, Singh I, Singh AK (2003). N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res. 971:1-8. Crossref |
||||
|
Selman WR, Tarr R, Landis DM (1997). Brain attack: emergency treatment of ischemic stroke. Am. Fam. Physician. 55:2655-2656. PubMed |
||||
|
Shibata H, Katsuki H, Okawara M, Kume T, Akaike A (2006). c-JunN-terminal kinase inhibition and alpha-tocopherol protect mid brain dopaminergic neurons from interferon-gamma/lipopolysaccharide-induced injury without affecting nitric oxide production. J. Neurosci. Res. 83:102-109. Crossref |
||||
|
Shin NH, Ryu SY, Lee H, Min KR, Kim Y (1998). Inhibitory effects of hydroxystilbenes on cyclooxygenase from sheep seminal vesicles. Planta. Med. 64(3):283-284. Crossref |
||||
|
Simonyi A, Wang Q, Miller RL, Yusof M, Shelat PB, Sun AY, Sun GY (2005). Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol. Neurobiol. 31:135-147. Crossref |
||||
|
Sims NR, Muyderman H (2010). Mitochondria, oxidative metabolism and cell death in stroke. Biochim. Biophys. Acta. 1802:80-91. Crossref |
||||
|
Sudlow CL,Warlow CP (1997). Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 28:491-499. Crossref |
||||
|
Suntres ZE, Shek PN (1996). Treatment of LPS-induced tissue injury: role of liposomal antioxidants. Shock 6(1):S57–S64. Crossref |
||||
|
Takata J, Ito S, Karube Y, Nagata Y, Matsushima Y (1997). Water-soluble prodrug of vitaminE for parenteral use and its effect on endotoxin-induced liver toxicity. Biol. Pharm. Bull. 20:204-209. Crossref |
||||
|
Tănăsescu R, Nicolau A, Ticmeanu M, Luca D, Caraiola S, Cojocaru IM, Frăsineanu A, Ionescu R, Hristea A, Ene A, Tănăsescu R, Baicuş C (2008). An immunological approach to cerebral ischemia (I). Immune cells and adhesion molecules. Rom. J. Intern. Med. 46(1):3-8. PubMed |
||||
|
Tuttolomondo A, Di Raimondo D, Pecoraro R, Arnao V, Pinto A, Licata G (2012). Inflammation in ischemic stroke subtypes. Curr. Pharm. Des.18(28):4289-4310. Crossref |
||||
|
Ulrich PT, Kroppensteddt S, Heimann A, Kempski O (1998). Laser-doppler scanning of local cerebral blood flow and reserve capacity and testing of motor and memory function in a chronic 2-vessel occlusion model in rats. Stroke 29:2412-2420. Crossref |
||||
|
Wexler BC (1970). Metabolic changes in response to acute cerebral ischemia following bilateral carotid artery ligation in arteriosclerotic versus nonarteriosclerotic rats. Stroke 1:112-121. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
